Frontlight ResearchEarly access
Metastatic breast cancer trials in Kazakhstan
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleHER2-positive Metastatic Breast Cancer in Kazakhstan
- Where
- Aktobe, Almaty, Astana, Karaganda, Oral, Petropavl, Semey, Shymkent, Taraz
- Age
- 18 years to 99 years
- People
- 240
- Run by
- AstraZeneca
See details and how to joinNCT07593196